Mounjaro (Tirzepatide)

Mounjaro is an innovative, once-weekly injectable medication designed to support weight management and type 2 diabetes care. It mimics the actions of GLP-1 and GIP hormones, helping regulate appetite, slow digestion, and improve blood sugar control. Available in a pre-filled pen for ease of use, Mounjaro offers a clinically proven solution for sustainable weight loss and metabolic health.

Key Benefits

• Clinically proven to support weight loss and type 2 diabetes management
• Dual-action on GLP-1 and GIP receptors for enhanced efficacy
• Reduces appetite and promotes a feeling of fullness
• Helps lower blood sugar and improve insulin sensitivity
• Convenient once-weekly pre-filled injection pen
• Proven results in clinical trials with significant weight reduction

🩺 Mounjaro® facts

Treatment type
GLP-1 + GIP injectable pen

Available strengths
2.5mg – 15mg

Weight loss in 9 months
Average 20.9% body weight

Active ingredient
Tirzepatide

Weight loss in 20 months
Average 25.3% of body weight

Possible Side Effects

• • Nausea
• • Vomiting
• • Diarrhoea
• • Decreased appetite
• • Constipation
• • Abdominal discomfort
• • Fatigue (less common)

Most side effects are mild and improve with time. Contact your doctor if side effects are persistent or severe.

Who Can Use Mounjaro?

Mounjaro is suitable for adults with:

Important: Always consult your doctor before starting Mounjaro.

Comparison: Mounjaro vs Other Treatments